Antipsychotic Drugs Linked to Increased Mortality Among Parkinson's Disease Patients
Penn and VA-led study analyzed medical records of 15,000 Parkinson’s patients
With Parkinson’s, there is a good chance that patients will experience some type of psychosis at some point during the course of their illness. During this time, most physicians prescribe antipsychotic drug to treat their symptoms. In a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, the University of Michigan Medical School and the Philadelphia and Ann Arbor Veterans Affairs (VA) Medical Centers, findings indicate that these antipsychotic drugs may be doing more harm than good to patients. Click here to read more on this study.
Microsurgery Course Zurich
March 29-April 1, 2017; Zurich, Switzerland
12th World Congress on Brain Injury
March 29-April 1, 2017; New Orleans
2017 National Neuroscience Review
March 31-April 1, 2017; National Harbor, Md.
Brain & Brain PET 2017
April 1-4, 2017; Berlin, Germany
Neurosurgical Society of America Annual Meeting 2017
April 2-5, 2017; Jacksonville, Fla.